2
A long-standing challenge in cancer drug manufacturing may be shifting. An international team of scientists has reported a major advance in how doxorubicin, a widely used chemotherapy drug, can be produced. Their work pinpoints and overcomes key molecular “bottlenecks” that have restricted natural production of the drug for more than 50 years. First approved in […]
Source link
